Gd(iii)-Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy.

ABSTRACT: Pt(iv) prodrugs have emerged as versatile therapeutics for addressing issues regarding off-target toxicity and the chemoresistance of classic Pt(ii) drugs such as cisplatin and carboplatin. There is significant potential for Pt(iv) complexes to be used as theranostic agents, yet there are currently no reported examples of Gd(iii)-Pt(iv) agents for simultaneous MR imaging and chemotherapy. Here we report the synthesis, characterization, and in vitro efficacy of two Gd(iii)-Pt(iv) agents, GP1 and GP2. Both agents are water soluble and stable under extracellularly relevant conditions but are reduced under intracellular conditions. Both are cytotoxic in multiple cancer cell lines, cell permeable, and significantly enhance the T ₁-weighted MR contrast of m

SUBMITTER: Adams CJ 

PROVIDER: S-EPMC8157322 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature